By Lina carolina 
The increasing legalization of marijuana across numerous states has fostered a perception of relative safety among the public. However, when juxtaposed with the well-established carcinogenic properties of tobacco, the scientific understanding of marijuana’s impact on cancer risk remains a complex and evolving area of research. Experts emphasize that while tobacco smoking is unequivocally linked to a multitude of cancers, particularly lung cancer, the precise mechanisms and extent of marijuana’s influence are still being meticulously investigated. Brooks Udelsman, MD, a thoracic surgeon affiliated with USC Surgery at Keck Medicine of USC, highlights that this ongoing scientific endeavor is crucial for providing the public with accurate risk assessments.
Emerging Evidence on Marijuana Use and Cancer Incidence
Recent scientific inquiries are shedding light on the potential correlation between marijuana consumption and an elevated risk of developing certain cancers. A significant study conducted by Keck Medicine, under the leadership of Niels Kokot, MD, an otolaryngologist at the USC Caruso Department of Otolaryngology — Head and Neck Surgery, has provided compelling data. This research indicated that individuals who engaged in substantial quantities of marijuana smoking exhibited a demonstrably higher likelihood of developing both small cell lung cancer and non-small cell lung cancer.
Further elaborating on the scope of these findings, Dr. Kokot and his research team also published a separate study that identified a pronounced association between daily marijuana use and an increased incidence of head and neck cancers. Their findings suggest that daily marijuana users were between 3.5 and 5 times more prone to developing these malignancies compared to non-users. The spectrum of head and neck cancers examined in this research encompasses those affecting the oral cavity, pharynx, larynx, oropharynx (including the tongue, tonsils, and the posterior wall of the throat), and adjacent salivary glands. This expansive categorization underscores the broad potential impact of marijuana on this critical anatomical region.
Quantifying the Risk: The "How Much is Too Much" Dilemma
A central challenge in the current scientific discourse surrounding marijuana and cancer is the absence of a clearly defined dose-response relationship. While the evidence linking heavy marijuana smoking to increased cancer risk continues to accumulate, researchers have yet to establish a precise threshold of use at which the risk begins to escalate significantly.
Dr. Udelsman articulates this uncertainty, stating, "What we don’t know right now is the dose relationship. So, if someone smokes marijuana occasionally once a week, once a month or a few times a year, do they still have that same risk? My suspicion is that there is probably minimal risk. All we know right now is that people who smoke a lot of marijuana — to the point that they develop a dependency on it or require hospital care or evaluation for it — do appear to have a higher cancer risk." This distinction between occasional and chronic, heavy use is a critical point of ongoing investigation.
Beyond lung and head and neck cancers, scientists are actively exploring potential links between heavy marijuana use and other forms of cancer, including bladder cancer and gastrointestinal cancers. The established association between tobacco smoking and an increased prevalence of bladder cancer, for instance, prompts researchers to investigate whether similar correlations exist for heavy marijuana smokers. "With tobacco, we do see an increased prevalence of bladder cancer. Whether that relationship is also the same for heavy marijuana smoking, we don’t know," Dr. Udelsman remarks. "That’s why we’re trying to determine what the risks are so that people can know what risks they’re taking."
The Nuances of Consumption: Edibles vs. Smoking
The method of marijuana consumption is another critical factor being scrutinized by researchers. While smoking has been the primary focus of many studies due to its direct impact on the respiratory system, alternative consumption methods, such as edibles, are gaining popularity. Current evidence suggests that non-smoking methods like edibles are less likely to pose a direct risk for lung cancer.
"Probably not," Dr. Udelsman responds when asked about the link between edibles and lung cancer. He elaborates, "The risk is harder to track because there isn’t a lot of data on it yet, but as of now there does not seem to be a relationship between edibles and lung cancer. We don’t yet know if there is a link to other types of cancers, however." This indicates that while the immediate concern for lung cancer might be lower with edibles, the broader implications for other cancers are still under investigation.
Unraveling the Biological Mechanisms of Risk
The scientific community is working to understand the biological pathways through which marijuana smoke might contribute to cancer development. Dr. Udelsman explains that any substance that induces prolonged inflammation can, over time, elevate cancer risk. Tobacco smoke, notorious for its complex chemical composition, contains over 7,000 chemicals, with approximately 70 identified as carcinogens. Intriguingly, some of these same carcinogenic compounds are also present in marijuana smoke.
Furthermore, research is exploring the role of THC (tetrahydrocannabinol), the primary psychoactive component of marijuana. THC has been associated with the conversion of polycyclic aromatic hydrocarbons (PAHs) into potentially harmful substances. PAHs are known to trigger inflammation and can lead to DNA damage. "Anytime inflammation and changes to DNA occur, you’re at risk for developing cancer," Dr. Udelsman states, underscoring the fundamental cellular processes involved in cancer initiation.
Secondhand Smoke: An Emerging Concern?
The potential health implications of secondhand marijuana smoke are also under examination, though conclusive evidence linking it to lung cancer remains elusive. Dr. Udelsman suggests that there could be a potential risk, as individuals exposed to secondhand marijuana smoke may inhale inflammatory particles that are believed to play a role in cancer development. While definitive data is still being gathered, the presence of inflammatory compounds in secondhand smoke warrants continued scientific scrutiny.
Specific Lung Cancers Associated with Marijuana Use
Lung cancer is broadly categorized into two main types: small cell lung cancer and non-small cell lung cancer. Historically, small cell lung cancer has been strongly associated with tobacco smoking. However, Dr. Udelsman indicates that this type of lung cancer may also be linked to marijuana smoking. "It’s almost unheard of to get small cell lung cancer without some type of inhalational injury," he notes, suggesting a potential role for inhaled substances beyond tobacco.
Similarly, non-small cell lung cancer appears with greater frequency among individuals who smoke marijuana. "We also see an increase in non-small cell lung cancer in smokers of both tobacco and marijuana, so both types are increased when compared to nonsmokers," he adds. This observation highlights that both major categories of lung cancer may be influenced by marijuana consumption, particularly in comparison to individuals who abstain from smoking altogether.
The Evolving Debate on Vaping and Cancer Risk
The advent and widespread adoption of electronic cigarettes, or vaping devices, initially fostered beliefs of reduced harm compared to traditional smoking. However, medical professionals are now observing a concerning rise in serious inflammatory lung diseases linked to vaping, although direct causality with cancer is not yet established.
"But we are starting to see some very severe inflammatory diseases — not cancers, but benign diseases — from vaping," Dr. Udelsman observes. The relatively short history of vaping as a common practice, spanning approximately 15 years, means that sufficient time has not yet elapsed for comprehensive long-term studies on its potential to cause cancer. This uncertainty extends to the vaping of marijuana.
"The data on vaping is very new, so we don’t know yet, but I’d worry about anything you’re breathing into your lungs because it infiltrates the cells and air sacs in your lungs, which can cause damage and put you at a higher risk for cancer," Dr. Udelsman cautions. This statement reflects a precautionary principle, emphasizing the potential for inhaled substances, regardless of their origin, to cause cellular damage and increase long-term health risks.
Distinguishing Occasional Use from Chronic, Heavy Exposure
Despite the growing body of evidence linking marijuana use to increased cancer risk, Dr. Udelsman maintains that recreational marijuana use is unlikely to trigger a widespread lung cancer epidemic. He differentiates between the potential harms of occasional versus chronic, heavy use.
"I worry less about occasional use and the slight inflammation that it might cause for a temporary period. Your body probably recovers from that very quickly, with very little damage," he asserts. His primary concern lies with sustained, high-level exposure: "I’m more worried about chronic, heavy exposure: people who are using marijuana every day, multiple times a day. That’s where I think you can start to build up injury. Those are the people data today shows are at risk for developing cancer, similar to tobacco."
This nuanced perspective underscores the importance of individual usage patterns in assessing cancer risk. For individuals who engage in heavy marijuana use, consultation with a healthcare provider is strongly recommended. Such discussions can facilitate a thorough evaluation of personal cancer risk, and determine the appropriateness of additional screening or follow-up medical care. As scientific understanding continues to advance, public health messaging will likely evolve to provide more precise guidance on navigating the complex relationship between marijuana consumption and long-term health outcomes. The ongoing research aims to provide clarity, enabling informed decision-making regarding personal health choices in an era of expanding cannabis legalization.
